semaglutide real results for Weight Loss: Before & After Semaglutide NYC | Weight Loss

Mounjaro's sales dip: How cheap generics are redrawing India's GLP-1 market The arrival of cheaper semaglutide alternatives signals that the Indian obesity drug market has moved from a launch-led boom into something more structurally competitive Eli Lilly's Mounjaro posted its first monthly sales drop in India in Marcha Rs 20-crore decline, from roughly Rs 135 crore in February to Rs 114 crorejust days after a clutch of Indian generics entered the country's booming GLP-1 market

Eli Lilly launched Mounjaro in India in March 2025, followed by Novo Nordisks Wegovy in June 2025

Of note, the number of TEAE during time exposed to treatment was the primary end point in PIONEER 10, which compared semaglutide 3 mg, 7 mg, and 14 mg to dulaglutide 0.75 mg

However, its influence in the body extends well beyond appearance

A Critical Analysis of the Clinical Use of Incretin-Based Therapies: Efficacy and Adverse Events

Messaging your provider, tracking shipments, requesting refills, and reviewing treatment plans all happen in a single interface that feels modern and responsive